Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.06%
+14.86%
-3.80%
-3.18%
-0.44%
WGS
GeneDx Holdings
$121.77
Strengths
Earnings are forecast to grow
Risk Analysis
Downgraded on weak valued
Chart
$114.22 (+6.61%)
$91.78 (+32.68%)
$71.22 (+70.98%)
$75.16 (+62.01%)
WGS has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Low volume
High volatilty
WGS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Rating
Rating
Downgraded on weak valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
WGS Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
WGS Street view is unimpressive and have negative views on the near-term outlook
Average key support and resistance price levels.
WGS Earnings
The TTM reflects 12-month period, providing review of WGS financial performance.
The company financial health has moderately improved over the past year
Financial Score
What is WGS current stock price?
What are WGS stock strengths?
What risks are associated with WGS stock?
When is WGS next earnings report?
What is WGS market cap and volume?
What is WGS's current Stock IQ?
Should I buy WGS stock right now?
Is WGS a Strong Buy right now?
What does a 'Strong Buy' rating mean for WGS?
What does a 'Strong Sell' rating mean for WGS?
What factors influence WGS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.06%
+14.86%
-3.80%
-3.18%
-0.44%
WGS
GeneDx Holdings
Current Price
$121.77
Stock Insights
Strengths
Earnings are forecast to grow
Risk Analysis
Downgraded on weak valued
Chart
$114.22 (+6.61%)
$91.78 (+32.68%)
$71.22 (+70.98%)
$75.16 (+62.01%)
WGS Analysts Opinion
WGS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Rating
Rating
Downgraded on weak valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
WGS Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
WGS Street view is unimpressive and have negative views on the near-term outlook
WGS has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Low volume
High volatilty
Average key support and resistance price levels.
WGS Earnings
The TTM data reflects the most recent 12-month period, providing overview of WGS financial performance.
WGS Financial Health
The company financial health has moderately improved over the past year
Financial Score
WGS Latest Analysis
4 Analysts Assess GeneDx Holdings: What You Need To Know. Throughout the last three months 4 analysts have evaluated GeneDx Holdings (NASDAQ:WGS) offering a diverse set of opinions from ish to bearish.The following table summarizes their recent ratings shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.1210010000000000100001100The 12-month price targets analyzed by analysts offer insights with an average target of $127.5 a high estimate o
Mon Oct 20, 2025
Canaccord Genuity Initiates Coverage of GeneDx Holdings (WGS) with Buy Recommendation. Fintel reports that on October 20 2025 Canaccord Genuity initiated coverage of GeneDx Holdings (NasdaqGS:WGS) with a Buy recommendation. Analyst Price Forecast Suggests 4.37% Upside
Mon Oct 20, 2025
WGS Crosses Above Average Analyst Target. In recent trading shares of GeneDx Holdings Corp (Symbol: WGS) have crossed above the average analyst 12-month target price of $118.18 changing hands for $118.35/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: downgrade o
Mon Oct 6, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.